Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
16 March 2017Website:
http://www.r1rcm.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:49:14 GMTDividend
Analysts recommendations
Institutional Ownership
RCM Latest News
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
NEW YORK, NY / ACCESSWIRE / October 23, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces it has filed a lawsuit against UiPath, Inc. ("UiPath" or the "Company") (NYSE:PATH) and certain of the Company's senior executives. If you suffered losses on your UiPath investment, you are encouraged to submit your information at https://www.bfalaw.com/cases/uipath-inc-investigation.
NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (Nasdaq:RCM) acquisition by New Mountain Capital for $13.25 per share. If you invested in R1 RCM, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/r1-rcm-inc.
What type of business is R1 RCM?
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah.
What sector is R1 RCM in?
R1 RCM is in the Healthcare sector
What industry is R1 RCM in?
R1 RCM is in the Health Information Services industry
What country is R1 RCM from?
R1 RCM is headquartered in United States
When did R1 RCM go public?
R1 RCM initial public offering (IPO) was on 16 March 2017
What is R1 RCM website?
https://www.r1rcm.com
Is R1 RCM in the S&P 500?
No, R1 RCM is not included in the S&P 500 index
Is R1 RCM in the NASDAQ 100?
No, R1 RCM is not included in the NASDAQ 100 index
Is R1 RCM in the Dow Jones?
No, R1 RCM is not included in the Dow Jones index
When was R1 RCM the previous earnings report?
No data
When does R1 RCM earnings report?
Next earnings report date is not announced yet